Search

everythinglearnresearchcommunity

for

Search:↓

Observers often disagree on ultrasound results for polycystic ovaries, needing better training for consistency.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

New treatments for PCOS focus on managing symptoms and improving fertility.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The combined therapy improved symptoms in PCOS patients.

Melatonin may help treat PCOS symptoms in rats.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.